메뉴 건너뛰기




Volumn 6, Issue 3, 2010, Pages 181-191

Long-term tolerability and effectiveness of oxymorphone extended release in patients with cancer

Author keywords

Cancer; Cancer pain; Chronic pain; Extension trial; Opioid; Oxymorphone

Indexed keywords

OXYMORPHONE;

EID: 77954604023     PISSN: 15517489     EISSN: None     Source Type: Journal    
DOI: 10.5055/jom.2010.0016     Document Type: Article
Times cited : (9)

References (33)
  • 2
    • 35348873634 scopus 로고    scopus 로고
    • Symptom burden among cancer survivors: Impact of age and comorbidity
    • Mao JJ, Armstrong K, Bowman MA, et al.: Symptom burden among cancer survivors: Impact of age and comorbidity. J Am Board Fam Med. 2007; 20(5): 434-443.
    • (2007) J Am Board Fam Med , vol.20 , Issue.5 , pp. 434-443
    • Mao, J.J.1    Armstrong, K.2    Bowman, M.A.3
  • 3
    • 33751022784 scopus 로고    scopus 로고
    • Multidisciplinary management of cancer pain: A longitudinal retrospective study on a cohort of end-stage cancer patients
    • Peng WL, Wu GJ, Sun WZ, et al.: Multidisciplinary management of cancer pain: A longitudinal retrospective study on a cohort of end-stage cancer patients. J Pain Symptom Manage. 2006; 32(5): 444-452.
    • (2006) J Pain Symptom Manage , vol.32 , Issue.5 , pp. 444-452
    • Peng, W.L.1    Wu, G.J.2    Sun, W.Z.3
  • 5
    • 53949113349 scopus 로고    scopus 로고
    • Prevalence and treatment of cancer pain in Italian oncological wards centres: A cross-sectional survey
    • Mercadante S, Roila F, Berretto O, et al.: Prevalence and treatment of cancer pain in Italian oncological wards centres: A cross-sectional survey. Support Care Cancer. 2008; 16(11): 1203-1211.
    • (2008) Support Care Cancer , vol.16 , Issue.11 , pp. 1203-1211
    • Mercadante, S.1    Roila, F.2    Berretto, O.3
  • 6
    • 33845230217 scopus 로고    scopus 로고
    • An assessment of methods used to evaluate the adequacy of cancer pain management
    • Russell PB, Aveyard SC, Oxenham DR: An assessment of methods used to evaluate the adequacy of cancer pain management. J Pain Symptom Manage. 2006; 32(6): 581-588.
    • (2006) J Pain Symptom Manage , vol.32 , Issue.6 , pp. 581-588
    • Russell, P.B.1    Aveyard, S.C.2    Oxenham, D.R.3
  • 7
    • 14844331712 scopus 로고    scopus 로고
    • Long-term follow-up of breast cancer survivors with post-mastectomy pain syndrome
    • Macdonald L, Bruce J, Scott NW, et al.: Long-term follow-up of breast cancer survivors with post-mastectomy pain syndrome. Br J Cancer. 2005; 92(2): 225-230.
    • (2005) Br J Cancer , vol.92 , Issue.2 , pp. 225-230
    • Macdonald, L.1    Bruce, J.2    Scott, N.W.3
  • 8
    • 18844378628 scopus 로고    scopus 로고
    • Palliative care needs of cancer patients in U.S. nursing homes
    • Johnson VM, Teno JM, Bourbonniere M, et al.: Palliative care needs of cancer patients in U.S. nursing homes. J Palliat Med. 2005; 8(2): 273-279.
    • (2005) J Palliat Med , vol.8 , Issue.2 , pp. 273-279
    • Johnson, V.M.1    Teno, J.M.2    Bourbonniere, M.3
  • 9
    • 33845863702 scopus 로고    scopus 로고
    • Pain management in the last six months of life among women who died of ovarian cancer
    • Rolnick SJ, Jackson J, Nelson WW, et al.: Pain management in the last six months of life among women who died of ovarian cancer. J Pain Symptom Manage. 2007; 33(1): 24-31.
    • (2007) J Pain Symptom Manage , vol.33 , Issue.1 , pp. 24-31
    • Rolnick, S.J.1    Jackson, J.2    Nelson, W.W.3
  • 10
    • 56749182291 scopus 로고    scopus 로고
    • Prevalence of undertreatment in cancer pain. A review of published literature
    • Deandrea S, Montanari M, Moja L, et al.: Prevalence of undertreatment in cancer pain. A review of published literature. Ann Oncol. 2008; 19(12): 1985-1991.
    • (2008) Ann Oncol , vol.19 , Issue.12 , pp. 1985-1991
    • Deandrea, S.1    Montanari, M.2    Moja, L.3
  • 12
    • 0003527864 scopus 로고    scopus 로고
    • World Health Organization: Geneva, Switzerland: WHO Office of Publication
    • World Health Organization: Cancer Pain Relief. Geneva, Switzerland: WHO Office of Publication, 1996.
    • (1996) Cancer Pain Relief
  • 13
    • 0028848482 scopus 로고
    • Validation of World Health Organization Guidelines for cancer pain relief: A 10-year prospective study
    • Zech DF, Grond S, Lynch J, et al.: Validation of World Health Organization Guidelines for cancer pain relief: A 10-year prospective study. Pain. 1995; 63(1): 65-76.
    • (1995) Pain , vol.63 , Issue.1 , pp. 65-76
    • Zech, D.F.1    Grond, S.2    Lynch, J.3
  • 15
    • 0029146394 scopus 로고
    • Opioid pharmacotherapy in the management of cancer pain: A survey of strategies used by pain physicians for the selection of analgesic drugs and routes of administration
    • Cherny NJ, Chang V, Frager G, et al.: Opioid pharmacotherapy in the management of cancer pain: A survey of strategies used by pain physicians for the selection of analgesic drugs and routes of administration. Cancer. 1995; 76(7): 1283-1293.
    • (1995) Cancer , vol.76 , Issue.7 , pp. 1283-1293
    • Cherny, N.J.1    Chang, V.2    Frager, G.3
  • 16
    • 31044445939 scopus 로고    scopus 로고
    • No pain relief from morphine? Individual variation in sensitivity to morphine and the need to switch to an alternative opioid in cancer patients
    • DOI 10.1007/s00520-005-0843-2
    • Riley J, Ross JR, Rutter D, et al.: No pain relief from morphine? Individual variation in sensitivity to morphine and the need to switch to an alternative opioid in cancer patients. Support Care Cancer. 2006; 14(1): 56-64. (Pubitemid 43119598)
    • (2006) Supportive Care in Cancer , vol.14 , Issue.1 , pp. 56-64
    • Riley, J.1    Ross, J.R.2    Rutter, D.3    Wells, A.U.4    Goller, K.5    Du Bois, R.6    Welsh, K.7
  • 17
    • 69849084738 scopus 로고    scopus 로고
    • Opioid switching and rotation in primary care: Implementation and clinical utility
    • Slatkin NE: Opioid switching and rotation in primary care: Implementation and clinical utility. Curr Med Res Opin. 2009; 25(9): 2133-2150.
    • (2009) Curr Med Res Opin , vol.25 , Issue.9 , pp. 2133-2150
    • Slatkin, N.E.1
  • 18
    • 0035059131 scopus 로고    scopus 로고
    • Breakthrough cancer pain: A randomized trial comparing oral transmucosal fentanyl citrate (OTFC) and morphine sulfate immediate release (MSIR)
    • Coluzzi PH, Schwartzberg L, Conroy JD, et al.: Breakthrough cancer pain: A randomized trial comparing oral transmucosal fentanyl citrate (OTFC) and morphine sulfate immediate release (MSIR). Pain. 2001; 91(1-2): 123-130.
    • (2001) Pain , vol.91 , Issue.1-2 , pp. 123-130
    • Coluzzi, P.H.1    Schwartzberg, L.2    Conroy, J.D.3
  • 19
    • 0017580705 scopus 로고
    • Comparisons of the analgesic effects of oral and intramuscular oxymorphone and of intramuscular oxymorphone and morphine in patients with cancer
    • Beaver WT, Wallenstein SL, Houde RW, et al.: Comparisons of the analgesic effects of oral and intramuscular oxymorphone and of intramuscular oxymorphone and morphine in patients with cancer. J Clin Pharmacol. 1977; 17(4): 186-198.
    • (1977) J Clin Pharmacol , vol.17 , Issue.4 , pp. 186-198
    • Beaver, W.T.1    Wallenstein, S.L.2    Houde, R.W.3
  • 20
    • 0035866624 scopus 로고    scopus 로고
    • Investigation of the selectivity of oxymorphone- And naltrexone-derived ligands via site-directed mutagenesis of opioid receptors: Exploring the "address" recognition locus
    • Metzger TG, Paterlini MG, Ferguson DM, et al.: Investigation of the selectivity of oxymorphone- and naltrexone-derived ligands via site-directed mutagenesis of opioid receptors: Exploring the "address" recognition locus. J Med Chem. 2001; 44(6): 857-862.
    • (2001) J Med Chem , vol.44 , Issue.6 , pp. 857-862
    • Metzger, T.G.1    Paterlini, M.G.2    Ferguson, D.M.3
  • 21
    • 1842480273 scopus 로고    scopus 로고
    • Pharmacokinetics and dose-proportionality of oxymorphone extended release and its metabolites: Results of a randomized crossover study
    • Adams MP, Ahdieh H: Pharmacokinetics and dose-proportionality of oxymorphone extended release and its metabolites: Results of a randomized crossover study. Pharmacotherapy. 2004; 24(4): 468-476.
    • (2004) Pharmacotherapy , vol.24 , Issue.4 , pp. 468-476
    • Adams, M.P.1    Ahdieh, H.2
  • 22
    • 33846635073 scopus 로고    scopus 로고
    • Efficacy and safety of OPANA ER (oxymorphone extended release) for relief of moderate to severe chronic low back pain in opioid-experienced patients: A 12-week, randomized, double-blind, placebo-controlled study
    • Hale ME, Ahdieh H, Ma T, et al.: Efficacy and safety of OPANA ER (oxymorphone extended release) for relief of moderate to severe chronic low back pain in opioid-experienced patients: A 12-week, randomized, double-blind, placebo-controlled study. J Pain. 2007; 8(2): 175-184.
    • (2007) J Pain , vol.8 , Issue.2 , pp. 175-184
    • Hale, M.E.1    Ahdieh, H.2    Ma, T.3
  • 23
    • 33846671273 scopus 로고    scopus 로고
    • A 12-week randomized placebo-controlled trial assessing the safety and efficacy of oxymorphone extended release for opioid-naive patients with chronic low back pain
    • Katz N, Rauck R, Ahdieh H, et al.: A 12-week randomized placebo-controlled trial assessing the safety and efficacy of oxymorphone extended release for opioid-naive patients with chronic low back pain. Curr Med Res Opin. 2007; 23(1): 117-128.
    • (2007) Curr Med Res Opin , vol.23 , Issue.1 , pp. 117-128
    • Katz, N.1    Rauck, R.2    Ahdieh, H.3
  • 24
    • 17144390270 scopus 로고    scopus 로고
    • Safety, tolerability, and effectiveness of oxymorphone extended release for moderate to severe osteoarthritis pain: A one-year study
    • McIlwain H, Ahdieh H: Safety, tolerability, and effectiveness of oxymorphone extended release for moderate to severe osteoarthritis pain: A one-year study. Am J Ther. 2005; 12(2): 106-112.
    • (2005) Am J Ther , vol.12 , Issue.2 , pp. 106-112
    • McIlwain, H.1    Ahdieh, H.2
  • 25
    • 3042595723 scopus 로고    scopus 로고
    • Establishing the dosage equivalency of oxymorphone extended release and oxycodone controlled release in patients with cancer pain: A randomized controlled study
    • Gabrail NY, Dvergsten C, Ahdieh H: Establishing the dosage equivalency of oxymorphone extended release and oxycodone controlled release in patients with cancer pain: A randomized controlled study. Curr Med Res Opin. 2004; 20(6): 911-918.
    • (2004) Curr Med Res Opin , vol.20 , Issue.6 , pp. 911-918
    • Gabrail, N.Y.1    Dvergsten, C.2    Ahdieh, H.3
  • 26
    • 13244272132 scopus 로고    scopus 로고
    • Effectiveness and safety of oral extended-release oxymorphone for the treatment of cancer pain: A pilot study
    • Sloan P, Slatkin N, Ahdieh H: Effectiveness and safety of oral extended-release oxymorphone for the treatment of cancer pain: A pilot study. Support Care Cancer. 2005; 13(1): 57-65.
    • (2005) Support Care Cancer , vol.13 , Issue.1 , pp. 57-65
    • Sloan, P.1    Slatkin, N.2    Ahdieh, H.3
  • 27
    • 20644431597 scopus 로고    scopus 로고
    • Efficacy and safety of opioid agonists in the treatment of neuropathic pain of nonmalignant origin: Systematic review and meta-analysis of randomized controlled trials
    • Eisenberg E, McNicol ED, Carr DB: Efficacy and safety of opioid agonists in the treatment of neuropathic pain of nonmalignant origin: Systematic review and meta-analysis of randomized controlled trials. JAMA. 2005; 293(24): 3043-3052.
    • (2005) JAMA , vol.293 , Issue.24 , pp. 3043-3052
    • Eisenberg, E.1    McNicol, E.D.2    Carr, D.B.3
  • 28
    • 52949098347 scopus 로고    scopus 로고
    • Titration with oxymorphone extended release to achieve effective long-term pain relief and improve tolerability in opioid-naive patients with moderate to severe pain
    • Rauck R, Ma T, Kerwin R, et al.: Titration with oxymorphone extended release to achieve effective long-term pain relief and improve tolerability in opioid-naive patients with moderate to severe pain. Pain Med. 2008; 9(7): 777-785.
    • (2008) Pain Med , vol.9 , Issue.7 , pp. 777-785
    • Rauck, R.1    Ma, T.2    Kerwin, R.3
  • 30
    • 33745960058 scopus 로고    scopus 로고
    • Long-term management of chronic pain with transdermal buprenorphine: A multicenter, open-label, follow-up study in patients from three short-term clinical trials
    • Likar R, Kayser H, Sittl R: Long-term management of chronic pain with transdermal buprenorphine: A multicenter, open-label, follow-up study in patients from three short-term clinical trials. Clin Ther. 2006; 28(6): 943-952.
    • (2006) Clin Ther , vol.28 , Issue.6 , pp. 943-952
    • Likar, R.1    Kayser, H.2    Sittl, R.3
  • 31
    • 65749098996 scopus 로고    scopus 로고
    • Long-term safety, tolerability, and efficacy of OROS hydromorphone in patients with chronic pain
    • Wallace M, Moulin DE, Rauck RL, et al.: Long-term safety, tolerability, and efficacy of OROS hydromorphone in patients with chronic pain. J Opioid Manag. 2009; 5(2): 97-105.
    • (2009) J Opioid Manag , vol.5 , Issue.2 , pp. 97-105
    • Wallace, M.1    Moulin, D.E.2    Rauck, R.L.3
  • 32
    • 70349832927 scopus 로고    scopus 로고
    • An open-label, 1-year extension study of the long-term safety and efficacy of once-daily OROS(R) hydromorphone in patients with chronic cancer pain
    • Hanna M, Tuca A, Thipphawong J: An open-label, 1-year extension study of the long-term safety and efficacy of once-daily OROS(R) hydromorphone in patients with chronic cancer pain. BMC Palliat Care. 2009; 8: 14.
    • (2009) BMC Palliat Care , vol.8 , pp. 14
    • Hanna, M.1    Tuca, A.2    Thipphawong, J.3
  • 33
    • 19544371019 scopus 로고    scopus 로고
    • Effectiveness and tolerability of the buprenorphine transdermal system in patients with moderate to severe chronic pain: A multicenter, open-label, uncontrolled, prospective, observational clinical study
    • Muriel C, Failde I, Mico JA, et al.: Effectiveness and tolerability of the buprenorphine transdermal system in patients with moderate to severe chronic pain: A multicenter, open-label, uncontrolled, prospective, observational clinical study. Clin Ther. 2005; 27(4): 451-462.
    • (2005) Clin Ther , vol.27 , Issue.4 , pp. 451-462
    • Muriel, C.1    Failde, I.2    Mico, J.A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.